26 May 2020 by AXXELIS
Covid-19 has exposed the limits of the pharmaceutical market model
The COVID-19 pandemic has presented the pharmaceutical industry with the opportunity to strengthen what some view as a tainted image. Abbott Laboratories is winning effusive praise for its introduction of a rapid Covid-19 test. Johnson & Johnson has ramped-up its advertising on Twitter to promote the company’s research into a vaccine for Covid-19. It is even airing an eight-episode reality television series showcasing its efforts, but what other effects have these uncertain times done to the Pharma industry?
Read the full article HERE